Similar Articles
1291 Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
1292 Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report
1293 Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
1294 Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
1295 Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
1296 Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma
1297 Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
1298 Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma
1299 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1300 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA